These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23472681)

  • 1. One doctor's misfortune boosts TB treatment activism.
    Bateman C
    S Afr Med J; 2013 Feb; 103(3):134-6. PubMed ID: 23472681
    [No Abstract]   [Full Text] [Related]  

  • 2. Compassionate use of bedaquiline in the treatment of pulmonary XDR-TB.
    Danckers M; Lesko MB; Adamson R; Leibert E
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1522-3. PubMed ID: 25517823
    [No Abstract]   [Full Text] [Related]  

  • 3. A mutation associated with clofazimine and bedaquiline cross-resistance in MDR-TB following bedaquiline treatment.
    Somoskovi A; Bruderer V; Hömke R; Bloemberg GV; Böttger EC
    Eur Respir J; 2015 Feb; 45(2):554-7. PubMed ID: 25359333
    [No Abstract]   [Full Text] [Related]  

  • 4. Bedaquiline in MDR/XDR-TB cases: first experience on compassionate use.
    Tiberi S; De Lorenzo S; Centis R; Viggiani P; D'Ambrosio L; Migliori GB
    Eur Respir J; 2014 Jan; 43(1):289-92. PubMed ID: 23988772
    [No Abstract]   [Full Text] [Related]  

  • 5. Direct observation of tuberculosis treatment.
    Mohapatra PR
    Lancet; 2001 May; 357(9269):1708. PubMed ID: 11428366
    [No Abstract]   [Full Text] [Related]  

  • 6. Limited-sampling strategies for therapeutic drug monitoring of moxifloxacin in patients with tuberculosis.
    Pranger AD; Kosterink JG; van Altena R; Aarnoutse RE; van der Werf TS; Uges DR; Alffenaar JW
    Ther Drug Monit; 2011 Jun; 33(3):350-4. PubMed ID: 21544017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Gupta R; Espinal MA; Raviglione MC
    Int J Tuberc Lung Dis; 2000 Nov; 4(11):1089-91. PubMed ID: 11092726
    [No Abstract]   [Full Text] [Related]  

  • 8. Compassionate use of bedaquiline in highly drug-resistant tuberculosis patients in Mumbai, India.
    Udwadia ZF; Ganatra S; Mullerpattan JB
    Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28331036
    [No Abstract]   [Full Text] [Related]  

  • 9. Summary for Clinicians: 2019 Clinical Practice Guideline Summary for the Treatment of Drug-Resistant Tuberculosis.
    Berger CA; Alipanah N; Kheir F; Ruminjo JK; Nahid P; Thomson C
    Ann Am Thorac Soc; 2020 Aug; 17(8):911-917. PubMed ID: 32464069
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tuberculosis--epidemiology, diagnostics and therapy].
    Gillissen A
    MMW Fortschr Med; 2016 Mar; 158(6):50-5; quiz 56. PubMed ID: 27084162
    [No Abstract]   [Full Text] [Related]  

  • 11. [Weight loss, fatigue, night sweats--tuberculosis might be the reason].
    Stiefelhagen P
    MMW Fortschr Med; 2009 Sep; 151(37):42, 44-5. PubMed ID: 19827427
    [No Abstract]   [Full Text] [Related]  

  • 12. My TB story.
    Lauten VA
    S Afr Med J; 2007 Feb; 97(2):103-4. PubMed ID: 17404668
    [No Abstract]   [Full Text] [Related]  

  • 13. [Characterization of multidrug-resistant tuberculosis during pregnancy in Campinas, State of São Paulo, Brazil, from 1995 to 2007].
    Oliveira HB; Mateus SH
    Rev Soc Bras Med Trop; 2011 Oct; 44(5):627-30. PubMed ID: 22031080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosing pulmonary tuberculosis].
    Schuurmans MM
    Ther Umsch; 2011 Jul; 68(7):369-75. PubMed ID: 21728154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons from a randomised clinical trial for multidrug-resistant tuberculosis.
    Padayatchi N; Mac Kenzie WR; Hirsch-Moverman Y; Feng PJ; Villarino E; Saukkonen J; Heilig CM; Weiner M; El-Sadr WM
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1582-7. PubMed ID: 23131255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis among household contacts of multidrug-resistant tuberculosis patients in Delhi, India.
    Singla N; Singla R; Jain G; Habib L; Behera D
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1326-30. PubMed ID: 22283889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
    Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bedaquiline (Sirturo) for multidrug-resistant tuberculosis.
    Med Lett Drugs Ther; 2013 Aug; 55(1423):66-8. PubMed ID: 23959388
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical aspects and therapy of tuberculosis].
    Höffken G; Deppermann KM
    Internist (Berl); 1995 Oct; 36(10):961-9. PubMed ID: 7499072
    [No Abstract]   [Full Text] [Related]  

  • 20. TMC207 becomes bedaquiline, a new anti-TB drug.
    Palomino JC; Martin A
    Future Microbiol; 2013 Sep; 8(9):1071-80. PubMed ID: 24020736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.